Wasatch Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Wasatch Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,800	Closed	-$381K	–	366
2016 Q4	$381K	Buy	6,800 +1,000	+17%	+$57.6K	0.01%	343
2016 Q3	$358K	Buy	5,800 +900	+18%	+$58.9K	0.01%	340
2016 Q2	$310K	Sell	4,900 -2,000	-29%	-$126K	﹤0.01%	361
2016 Q1	$414K	Sell	6,900 -5,100	-43%	-$312K	0.01%	349
2015 Q4	$840K	Sell	12,000 -500	-4%	-$35.4K	0.01%	340
2015 Q3	$829K	Sell	12,500 -18,100	-59%	-$1.41M	0.01%	334
2015 Q2	$2.4M	Hold	30,600	–	–	0.03%	292
2015 Q1	$2.34M	Hold	30,600	–	–	0.02%	282
2014 Q4	$2.04M	Hold	30,600	–	–	0.02%	312
2014 Q3	$1.95M	Sell	30,600 -21,000	-41%	-$1.3M	0.02%	315
2014 Q2	$3.15M	Hold	51,600	–	–	0.03%	295
2014 Q1	$2.92M	Sell	51,600 -4,000	-7%	-$227K	0.03%	294
2013 Q4	$2.97M	Hold	55,600	–	–	0.03%	290
2013 Q3	$2.56M	Hold	55,600	–	–	0.03%	290
2013 Q2	$2.35M	Buy	+55,600	New	+$2.31M	0.03%	303

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wasatch Advisors's PJP Position: Q1 2017 in Review

Wasatch Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2017, closing a stake of 6,800 shares — an estimated $381K sold.

Wasatch Advisors first reported a position in PJP in Q2 2013 and held it in 15 quarters. The position peaked at $3.15M in Q2 2014. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2017.

Wasatch Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
Wasatch Advisors sold 6,800 Invesco Pharmaceuticals ETF shares in Q1 2017, an estimated $381K.
Wasatch Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 15 quarters.
Wasatch Advisors's Invesco Pharmaceuticals ETF position peaked at $3.15M in Q2 2014.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2017.

Based on Wasatch Advisors's 13F filing for Q1 2017, filed 15 May 2017.